Royal dsm-firmenich, a global purpose-led science-based company, confirms that it is resuming Rovimix® Vitamin A production in Sisseln, Switzerland.
In November 2022, the firm announced a temporary halt to Vitamin A production at the site.
The challenging cost environment cited in 2022 spans energy, raw materials and process material costs, continues in 2023.
Restarting production will allow dsm-firmenich to serve its loyal customers with animal nutrition premix solutions ahead of the shutdown for lifetime extension work planned for the Vitamin A line this summer.
The ongoing geopolitical and economic turbulence highlights the importance of maintaining resilient vitamin supply which plays a critical role in food security.
dsm-firmenich is committed to sustainable production of the highest quality feed additives, including the longstanding Rovimix® product range, with a strong production base in Europe, in alignment with the company’s aim to generate sustainable profitable growth.
Royal dsm-firmenich is a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet. dsm-firmenich’s purpose is to create brighter lives for all. dsm-firmenich’s products and solutions address some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at https://www.dsm.com/.
27 February 2023
We detected that you are visitng this page from United States. Therefore we are redirecting you to the localized version.